Can aromatase inhibitors cause forgetfulness in women with breast cancer ?
Karatas, F.; Akin, S.; Babacan, T.; Sever, A.R.; Altundag, K.
Journal of BUON Official Journal of the Balkan Union of Oncology 20(3): 935
2015
ISSN/ISBN: 1107-0625 PMID: 26214652 Document Number: 683728
Document emailed within 1 workday
Related Documents
Kao, Y.C.; Okubo, T.; Sun, X.Z.; Chen, S. 1999: Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women Anticancer Research 19(3a): 2049-2056Harvey, H.A. 1998: Emerging role of aromatase inhibitors in the treatment of breast cancer Oncology 12(3 Suppl 5: 32-35
Bershteĭn, L.M.; Barchuk, A.S.; Gershfel'd, E.D.; Kovalevskiĭ, A.I.; Maksimov, S.I.; Danilova, M.A.; Barash, I.A.; Meshkova, I.E.; Moiseenko, V.M.; Novik, A.V.; Pozharisskiĭ, K.M.; Semiglazov, V.F.; Tsyrlina, E.V.; Chernobrovkina, A.E. 2007: Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer Voprosy Onkologii 53(1): 7-13
Fukuoka, M.; Kitawaki, J.; Yamamoto, T.; Okada, H. 1991: Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors Nihon Sanka Fujinka Gakkai Zasshi 43(12): 1667-1673
De Jong, P.C.; van de Ven, J.; Nortier, H.W.; Maitimu-Smeele, I.; Donker, T.H.; Thijssen, J.H.; Slee, P.H.; Blankenstein, R.A. 1997: Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole Cancer Research 57(11): 2109-2111
Altundag, K. 2018: Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1559-1560
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463
Tsukagoshi, S. 2006: Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 859-863
Stein, R.C.; Dowsett, M.; Davenport, J.; Hedley, A.; Ford, H.T.; Gazet, J.C.; Coombes, R.C. 1990: Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A Cancer Research 50(5): 1381-1384
Brandt, M.E.; Puett, D.; Garola, R.; Fendl, K.; Covey, D.F.; Zimniski, S.J. 1988: Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy Progress in Clinical and Biological Research 262: 65-84
Irawan, C.; Abdulmuthalib 2005: The role of aromatase inhibitor (AI) in the treatment of breast cancer Acta Medica Indonesiana 37(1): 43-48
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Tarkowski, R.; Skrzypczak, M.; Winiarczyk, S.; Kotarski, J.; Jakowicki, J.A.; Jakimiuk, A.J. 2000: Aromatase (P450AROM) mRNA expression in normal, hyperplastic and malignant endometrium and aromatase activity in endometrial cancer tissue culture Ginekologia Polska 71(3): 130-135
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Utsumi, T. 1989: Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue Nihon Geka Gakkai Zasshi 90(6): 920-927
Kuria, I.M.; Petekkaya, I.; Hasanov, E.; Babacan, T.; Dizdar, O.; Altundag, K. 2012: Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 798-799
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Bandoh, K.; Ishizuka, Y.; Sato, M. 1995: Effects of 3-[N-(2-chlorobenzyl)amino]-6-(1H-imidazol-1-yl) pyridazine dihydrochloride on various aromatase enzyme systems and experimental breast cancer Arzneimittel-Forschung 45(8): 897-900
Baba, S.; Oji, Y.; Teramoto, M.; Kawabata, K.; Saito, A. 2009: A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1905-1906
Barni, S.; Lissoni, P.; Meregalli, S.; Ardizzoia, A.; Mengo, S.; Musco, F.; Merlini, D.; Tancini, G. 1998: Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancer Tumori 84(1): 45-47